About: The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 16 September 2010

AttributesValues
rdf:type
description
  • wetenschappelijk artikel (nl)
  • article scientifique publié en 2010 (fr)
  • наукова стаття, опублікована у вересні 2010 (uk)
  • im September 2010 veröffentlichter wissenschaftlicher Artikel (de)
  • scientific article published on 16 September 2010 (en)
  • artículu científicu espublizáu en setiembre de 2010 (ast)
publication date
publication date
author name string
author name string
  • Renata D'Incà
  • Alessandro Armuzzi
  • Vito Annese
  • Anna Kohn
  • Livia Biancone
  • Maurizio Vecchi
  • Gilberto Poggioli
  • Ambrogio Orlando
  • Claudio Papi
  • Fabiana Castiglione
  • Italian Group for the study of Inflammatory Bowel Disease
  • Aurora Bortoli
  • Italian Society of Gastroenterology
rdfs:label
  • The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease (en)
  • The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease (nl)
skos:prefLabel
  • The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease (en)
  • The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease (nl)
name
  • The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease (en)
  • The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease (nl)
author
author
title
title
  • The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease (en)
page(s)
page(s)
  • 1-20
instance of
instance of
main subject
main subject
PubMed ID
PubMed ID
PubMed ID
  • 20843756
published in
published in
issue
volume
issue
  • 1
volume
  • 43
DOI
DOI
DOI
  • 10.1016/J.DLD.2010.07.010
is about of
is cites work of
is cites work of
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software